Giancarlo Icardi is an expert in Infectiology at Ospedale Policlinico San Martino (Italy). As of October 2026, ScienceLeadR ranks Giancarlo Icardi in the top 1% of experts worldwide for Pneumonia, Coronavirus Infections and COVID-19. Giancarlo Icardi has authored 388 publications, the most recent in 2027, and is an investigator in 12 clinical trials. SLR score: 1,132 (community average: 125). How the SLR is computed.

LeadR Profile

Giancarlo Icardi Ospedale Policlinico San Martino Italy
1 132 ScienceLeadR Reputation 1132
Network Map

Infectiology

Subspecialties: Public Health - Preventive Medicine - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1997 - 2027

Source: PubMed

University of Genoa

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 388

Citations

Citations: 9 123 1st author: 13 Last author: 108 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Adjuvanted Influenza Vaccines Versus Other Influenza Vaccines in Adults Aged ≥60 Years: A Systematic Review and Meta-Analysis of Relative Effectiveness for Preventing Influenza-Related Hospitalization.
PMID 42931412 — hospitalization, vaccines, aged, influenza, human, influenza vaccines, records
Vaccines (Basel)20260
Maternal Immunization Against Respiratory Syncytial Virus: An Updated WAidid Consensus Document on Evidence, Implementation, and Public Health Priorities.
PMID 42797588 — respiratory syncytial viruses, epidemiology, immunization, parturition, vaccines, antibodies, public health, vaccination, viruses, antibodies, monoclonal, infant
Vaccines (Basel)20260
Coverage and appropriateness of influenza vaccination in adults ≥ 60 y: Provider contribution and adherence to Italian national recommendations.
PMID 42788870 — immunization, vaccines, pharmacies, vaccination, influenza, human
Hum Vaccin Immunother20260
Multicentre outbreak of Candida viswanathii bloodstream infections linked to contaminated milrinone, Italy, April to October 2025.
PMID 42725369 — milrinone, sepsis, communicable diseases, candida, infections
Euro Surveill20260
High-dose influenza vaccines in older adults: benefits and gaps.
PMID 42476161 — vaccines, influenza, human, influenza vaccines, healthy aging
Lancet Healthy Longev20271

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 8
N/A 2
Phase 2 1
Phase 4 1

By status:

Completed 12

By type:

Interventional 11
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 1
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 5

LeadR Networks

Main global connection map